Center for Global Health Policy and Politics

Press

Press

Crowley, Kavanagh, and Holmes on FDA’s Approval of Lenacapavir for HIV Prevention

This afternoon, the FDA approved Gilead’s drug, lenacapavir, a powerful HIV prevention drug that only requires two shots a year. The O’Neill Institute for National and Global Health Law issued…

June 18, 2025

Publication

Zero-Draft Framework for Tracking Implementation of the Pandemic Agreement

The Pandemic Agreement directs the Conference of Parties (COP) to create a mechanism to facilitate and strengthen implementation, including by monitoring key commitments and progress. In support of…

May 21, 2025

Press

Dr. Matthew M. Kavanagh on First-ever Pandemic Agreement

The O’Neill Institute issued the following statement from Dr. Matthew M. Kavanagh, director of the Center for Global Health Policy and Politics, in response to Member States of the WHO formally…

May 20, 2025